Abstract
The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it is possible to use killed and inactivated vaccines. Preliminary recommendations are given for COVID-19 vaccination, taking into account the MS disease modifying therapies.
Author supplied keywords
Cite
CITATION STYLE
Khachanova, N. V., Totolyan, N. A., Vlasov, Y. V., Sivertseva, S. A., Davydovskaya, M. V., Evdoshenko, E. P., … Boyko, A. N. (2021). COVID-19 vaccination guidelines for patients with multiple sclerosis. Nevrologiya, Neiropsikhiatriya, Psikhosomatika, 13(2), 157–161. https://doi.org/10.14412/2074-2711-2021-2-157-161
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
